In light of medicare advancements and the rising prevalence of life-threatening diseases, healthcare professionals are gradually making a shift toward injectable drug delivery systems from the hitherto oral medication solutions. The injectable drug delivery market is, according to industry analysis, estimated to be around a staggering US$ 49.44 billion, as of 2024. With the integration of telemedicine services, in the developing and developed parts of the world, this market is further slated to follow an upward surge.

Category-wise Insights

Country-wise Insights

The statistic shows the revenue of the global injectable drug delivery market in 2016 and a forecast for 2025. In 2016, the global injectable drug delivery market generated 16.73 billion U.S. dollars in revenue.

The statistic shows the distribution of the global injectable drug delivery market in 2016 and a forecast for 2025. In 2016, pen injectors accounted for 69 percent of the global injectable drug delivery market.

Explore the detailed segmentation analysis of the Injectable Drug Delivery market. Understand detailed breakdown for each segment and uncover market opportunities.

Explore the Injectable Drug Delivery Devices Market trends! Covers key players, growth rate 8.3% CAGR, market size $75.28 Billion, and forecasts to 2034. Get insights now!

The Report Covers Global Injectable Drug Delivery Devices Market Share & Trends and it is Segmented by Device Type (Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices), by Therapeutic Application (Cardiovascular Devices, Oncology, Diabetes, Autoimmune Disorders, Hepatitis, and Other Therapeutic Application), and by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above segments.

Snapshot img

Injectable Drug Delivery Devices Market Size 2024-2028

The injectable drug delivery devices market size is forecast to increase by USD 29.56 billion at a CAGR of 10.8% between 2023 and 2028.

The market is experiencing significant growth due to the increasing prevalence of chronic diseases such as infectious diseases, autoimmune diseases, hormonal disorders, cancer, and the need for immunization. This growth is particularly prominent in emerging countries. However, the market is subject to stringent regulations to ensure drug administration safety and patient education. Needle-free injectors are gaining popularity due to their ability to reduce pain and improve patient compliance. The market is also witnessing a shift from traditional vial-and-syringe methods to auto-injectors and pre-filled syringes for drug containment and convenience. Biologics and other complex drugs are driving the demand for advanced delivery systems, including intramuscular, subcutaneous, and intradermal delivery methods. Despite these opportunities, challenges such as high development costs and the need for continuous innovation remain. To stay competitive, market players must focus on addressing these challenges and meeting the evolving needs of patients and healthcare providers.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The injectable drug delivery devices market represents a significant segment in the pharmaceutical industry, driven by the increasing prevalence of chronic diseases and the need for advanced medication administration solutions. These devices offer several advantages over traditional injection methods, including localized delivery, improved patient compliance, and reduced healthcare costs. Medication delivery systems, such as autoinjectors and prefilled syringes, have gained popularity in the administration of various therapeutic classes, including subcutaneous drugs for hereditary angioedema (HAE), infectious disorders like tuberculosis (TB), HIV, and AIDS, and chronic diseases such as diabetes, cancer, and autoimmune disorders. Intravenous administration of chronic infectious diseases' medications, such as antibiotics for medication resistance, also benefits from advanced injectable drug delivery devices. Smart solutions are increasingly being integrated into injectable drug delivery devices to enhance disease management. These devices offer features like patient identification, dosage error reduction, and real-time monitoring, ensuring optimal treatment outcomes and patient safety.



The market is diverse, catering to various therapeutic areas and patient needs. Autoinjectors and wearable injectors have emerged as popular choices for self-administration, particularly in the case of chronic diseases like diabetes and cardiovascular diseases. In summary, the injectable drug delivery devices market is witnessing substantial growth due to the increasing prevalence of chronic diseases, the need for advanced medication administration solutions, and the integration of smart technologies. The market is expected to continue its expansion, driven by ongoing research and development efforts and the increasing demand for convenient and effective medication delivery systems.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Advanced injectable drug delivery devices
  Conventional injectable drug delivery devices


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Product Insights

The advanced injectable drug delivery devices segment is estimated to witness significant growth during the forecast period.

The market encompasses pre-filled syringes, injectable pens, auto-injectors, and needle-free injectors. The pharmaceutical sector is experiencing significant growth in biopharmaceuticals, leading to an escalating demand for sophisticated drug delivery devices, specifically within the self-injectable devices segment. Approximately 60% of drugs undergoing clinical trials are biologics, which require parenteral administration. Over 900 biologics and medications are in development for various diseases, with the majority utilizing self-injectable devices as their preferred delivery system. Self-injectable devices offer numerous advantages for parenteral drug administration, including ease of use, reliability, and convenience.

Infectious diseases, autoimmune disorders, hormonal imbalances, cancer, and immunization are among the conditions treated with these devices. Intramuscular, subcutaneous, and intradermal deliveries ar

The report covers Europe Injectable Drug Delivery Devices Market Trends and it is Segmented by Device Type (Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices [Prefilled Syringes, Injectable Pens, Auto-Injectors, Needle-free Injectors, and Other Device Types]), Therapeutic Application (Cardiovascular Disease, Diabetes, Oncology, Autoimmune Disorders, Hepatitis, and Other Therapeutic Applications), and Geography (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe). The market size and forecasts are provided in terms of value (USD million) for all the above segments.

Global Injectable Drug Delivery Market Size By Type, By End User, By Geographic Scope And Forecast

Global Injectable Drug Delivery Market reached US$ 744.3 million in 2024 and is expected to reach US$ 1258.4 million by 2033

[213+ Pages Report] The global injectable drug delivery devices market size is expected to grow from USD 618 billion in 2021 to USD 1683 billion by 2030, at a CAGR of 10.25% from 2022-2030

Injectable drug delivery market is segmented into devices. Market is estimated to grow over $37.47 billion by 2025. Injectable drug delivery market report by BIS Research provides deep market insight that will help your business to grow.

The size and share of the market is categorized based on Application (Cardiovascular Diseases, Diabetes, Regenerative Medicine, Oncology, Pain Management, Hepatitis C, Auto Immune Disorders, Others) and Product (Conventional Drug Delivery, Novel Drug Delivery) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The injectable drug delivery devices market size was over USD 123.2 billion in 2024 and is projected to reach USD 300.52 billion by 2037, growing at around 7.1% CAGR during the forecast period i.e., between 2025-2037. Asia Pacific industry is set to dominate majority revenue share by 2037, propelled by increasing incidence of chronic disorders in the region.

Global Injectable Drug Delivery Market size was worth around USD 697.59 million in 2023 and is predicted to grow to around USD 1493.96 million by 2032 a CAGR of 8.83%.

Innovations in drug delivery technologies are enhancing the effectiveness and safety of injectable devices, further enabling the market to grow at a significant CAGR from 2024 to 2031.

Europe Injectable Drug Delivery Devices Market: Definition/Overview

Injectable drug delivery devices are specialized medical instruments designed to administer medications directly into a patient’s body through injections. These devices encompass a variety of formats, including syringes, autoinjectors, and wearable infusion systems, which enable precise and controlled delivery of drugs for various therapeutic applications. They are particularly valuable for administering biologics, vaccines, and chronic disease treatments, as they facilitate self-administration and improve patient compliance.

Stay updated with the latest Injectable Drug Delivery Market News. Get insights on recent mergers, acquisitions, and key industry developments.

Snapshot img

Drug Delivery Devices Market Size 2024-2028

The drug delivery devices market size is forecast to increase by USD 85.1 billion at a CAGR of 6.2% between 2023 and 2028.

The market is experiencing significant growth due to the increasing prevalence of chronic conditions and the rising adoption of self-administering systems. Self-injectable devices, including auto-injectors and jet-injectors, are gaining popularity for their convenience and effectiveness in delivering drugs directly to the target site. However, bioavailability hurdles remain a challenge in oral delivery systems, leading to the increasing use of injectable routes. Pharmaceutical companies are investing heavily in research and development to address these challenges and create more efficient drug delivery systems.In healthcare, Retail pharmacies and hospital pharmacies are key distribution channels for these devices, ensuring easy access for patients. Stringent government regulations ensure the safety and efficacy of these devices, making them a reliable option for patients. The market is expected to continue growing as technology advances and new applications for drug delivery systems emerge.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

 The market represents a significant segment within the pharmaceutical industry, offering innovative solutions for the effective and efficient administration of active pharmaceutical ingredients (APIs) in various therapeutic areas. These devices cater to both chronic diseases and non-chronic diseases, and their usage extends to home-care environments, retail pharmacies, hospital pharmacies, and online pharmacies. Advanced technology plays a crucial role in the development of drug delivery devices. Next-generation technologies, such as self-administering systems, auto-injectors, pen injectors, jet-injectors, prefilled syringes, and smart sensors, have gained popularity due to their patient-friendly designs and improved accuracy. In the context of chronic diseases, drug delivery devices have proven to be essential for targeted medication delivery.
Biologics drugs, which often require specific delivery methods, have particularly benefited from these advancements. The pharmaceutical industry's focus on diagnosis and treatment has led to the integration of drug delivery devices in various vaccination drives and therapeutic areas. Oral drug delivery and injectable drug delivery systems have shown remarkable progress, offering enhanced patient compliance and convenience. Homecare solutions have emerged as a key area of growth within the market. These devices enable patients to administer medications in the comfort of their homes, reducing the need for frequent hospital visits and improving overall patient care.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Route Of Administration

  Oral
  Injectable
  Pulmonary
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia



  Rest of World (ROW)

By Route Of Administration Insights

The oral segment is estimated to witness significant growth during the forecast period.

The market for Drug Delivery Devices encompasses various types of devices used for administering drugs, including Injection Devices, Oral Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, and Nasal Drug Delivery. Among these, the segment for Oral Drug Delivery is significant due to its ease of use, non-invasive nature, and cost-effectiveness. This segment includes drugs in the form of capsules, tablets, syrups, solutions, and suspensions

Furthermore, orally administered drugs can be targeted to specific areas within the gastrointestinal tract to treat various conditions, including cancer, inflammation, infections, and bowel diseases. Advancements in pharmaceutical technologies and oral drug delivery systems, such as lipid-based carriers, nanocarriers, and micelles, are enhancing oral drug absorption, thereby improving therapeutic effectiveness. Hence, such factors are fuelling the growth of this segment during the forecast period.

Get a glance at the market report of share of various segments Request Free Sample

The oral segment was valued at USD 85.50 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 52% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sampl

Syringes: Traditional devices used for subcutaneous and intramuscular injections.Pens: Convenient and user-friendly devices designed for self-administration.Infusion Pumps: Used to deliver large volumes of fluids or medications over an extended period.Controlled-Release Implants: Long-lasting devices that release drugs at a predetermined rate.Transdermal Patches: Non-invasive devices that deliver drugs through the skin. Recent developments include: March 2020: In 50-subject human clinical research for their investigational device, the BD Libertas Wearable Injector, Becton, Dickinson, and Company reported that they had completed their purchases., April 2020: The AJOVY auto-injector has been made available in the United States, according to TEVA Pharmaceuticals USA, Inc. As a prophylactic precaution, this gadget is made to cure adult migraines., January 2023: The extended-release injectable suspension form of Rykindo® (risperidone) was authorized by the FDA in January 2023. It is prescribed for people with bipolar I disorder as monotherapy or as supplementary therapy to lithium or valproate, and as a biweekly treatment for schizophrenia. Luye Pharmaceutical has created the atypical antipsychotic Rykindo®. The drug's active component, risperidone, is delivered using long-acting and extended-release microsphere technology and is administered via intramuscular injection. As a result, this population now has a promising therapeutic option thanks to the approval of the biweekly extended-release injectable., February 2023: With the launch of its first product, West Ready Pack with Corning Valor RTU Vials utilizing SG EZ-fill technology, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announces the expansion of its landmark collaboration with Corning Incorporated. The combination of Valor® RTU Vials with SG EZ-fill® technology results in improved drug storage and delivery, increased availability of critically important public health medications, and increased productivity. Injectable drug storage and distribution are both improved by this strategic partnership by two industry leaders, elastomer and glass system manufacturers. West and Corning are teaming up to create innovative packaging and delivery systems.. Notable trends are: Risk of infectious diseases to propel market growth.

Injectable Drug Delivery Devices Market Analysis

The Injectable Drug Delivery Devices Market is experiencing sign...